Cipla said it received approval for its HIV treatment combination medicine 'TLD' from the South African Health Products Regulatory Authority (SAHPRA). The drug will be manufactured at Cipla's facilities in Durban and Uganda. The announcement was made after market hours yesterday, 11 September 2018.
Sun Pharmaceutical Industries will be watched. With reference to the media report, "Sun Pharma's Mohali plant on FDA radar", the drug major clarified that the US Food and Drug Administration (USFDA) is conducting an inspection of the company's Mohali facility (Punjab, India). The inspection started yesterday, 10 September 2018 and is ongoing. The clarification was issued after market hours yesterday, 11 September 2018.
Wipro and Duck Creek Technologies, the P&C insurance industry's leading Saas software provider, announced a relationship whereby Wipro will offer a broad array of implementation services and related software and data solutions for its insurance industry customers around the world. Wipro will offer systems integration, configuration, and support services for the Duck Creek Platform, which includes solutions for policy, rating, billing, claims, data insights, and digital engagement. Together, Wipro and Duck Creek will help insurers meet rapidly evolving consumer expectations in their digital transformation journey. The announcement was made after market hours yesterday, 11 September 2018.
Redington (India) announced that a meeting of the board of directors of the company is fixed on 17 September 2018 in Chennai, to consider a proposal to buyback the fully paid-up equity shares of the company. The announcement was made after market hours yesterday, 11 September 2018.
Godrej Agrovet announced that the meeting of the board of directors of the company is scheduled on 14 September 2018, to consider and approve scheme of amalgamation of Astec LifeSciences, a subsidiary of the company, with the company and also to discuss on business strategies. The announcement was made after market hours yesterday, 11 September 2018.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
